News

“Life-changing” SMA therapies to be available on NHS in long-term

Hundreds more children with muscle-wasting condition spinal muscular atrophy (SMA) are to be offered potentially “life-changing” therapy on the NHS which could help them live years longer and attend primary school. From today, 2 innovative treatments for SMA – nusinersen and risdiplam – will be made routinely available on the NHS in England following an access scheme to collect more evidence, giving hundreds of families long term-certainty. NHS […]